Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome

Rheumatology International

Volumn 32, Issue 1, 2012, Pages 249-251

  Shendi, Hiba M ^a   Walsh, Deirdre ^a,b   Edgar, J David M ^a  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b NORTHERN HEALTH AND SOCIAL CARE TRUST   (United Kingdom)

Author keywords

Adverse effects; Anakinra; Etanercept; Hyper IgD and periodic fever syndrome (HIDS); Treatment

Indexed keywords

C REACTIVE PROTEIN; COLCHICINE; ETANERCEPT; IMMUNOGLOBULIN D; MEVALONATE KINASE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ABDOMINAL DISCOMFORT; ARTICLE; CASE REPORT; CHILD; DIARRHEA; DRUG DOSE INCREASE; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FEVER; GENE MUTATION; HETEROZYGOTE; HUMAN; HYPERIMMUNOGLOBULINEMIA D AND PERIODIC FEVER SYNDROME; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY TEST; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE;

ANTIRHEUMATIC AGENTS; CHILD; FEMALE; FEVER; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MEVALONATE KINASE DEFICIENCY; RECEPTORS, TUMOR NECROSIS FACTOR; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84857115753     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-009-1322-8     Document Type: Article

References (19)

1. JPH Drenth L Cuisset G Grateau C Vasseur SD van de Velde-Visser JG de Jong JS Beckmann JWM van der Meer M Delpech 1999 Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome Nat Genet 22 178 181 10369262 10.1038/9696 1:CAS:528:DyaK1MXjvVelsbc%3D (Pubitemid 29264814)
2. JPH Dreneth CJ Haagsma JW van der Meer 1994 Hyperimmunoglobulinaemia D and periodic fever syndrome. The clinical spectrum in a series of 50 patients. International hyper-IgD study group Medicine (Baltimore) 73 133 144
3. JC van der Hilst EJ Bodar KS Barron J Fenkel JPH Drenth JWM van der Meer A Simon, et al. 2008 Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulin D syndrome Medicine (Baltimore) 87 301 310 10.1097/MD.0b013e318190cfb7
4. HJ Lachmann HJ Goodman PA Andrews H Gallagher J Marsh S Breuer DM Rowczenio A Bybee PN Hawkins 2006 AA amyloidosis complicating hyperimmunoglobulinaemia D with periodic fever syndrome: a report of two cases Arthritis Rheum 54 2010 2014 16732551 10.1002/art.21901 1:CAS:528: DC%2BD28Xms1Sisrc%3D (Pubitemid 43877953)
5. V Prietsch E Mayatepek H Krastel D Haas D Zundel HR Waterham RJ Wanders KM Gibson GF Hoffman 2003 Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum Paediatrics 111 258 261 10.1542/peds.111.2.258 (Pubitemid 36177141)
6. J de Dios Garcia-Diaz MJ Alvarez-Blanco 2001 Glucocorticoids but not NSAID abort attacks in hyper-IgD, periodic fever syndrome J Rheumatol 28 925 926 11327283 (Pubitemid 32246979)
7. PA Ostuni P Lazzarin G Ongaro R Gusi S Todesco PF Gambari 1988 Hyper IGD syndrome: a new case treated with colchicine Clin Rheumatol 7 398 401 3229086 10.1007/BF02239200 1:STN:280:DyaL1M7lt1Wnsw%3D%3D (Pubitemid 19235980)
8. A Simon E Drewe JW van der Meer RJ Powell RI Kelley AF Stalenhoef JP Drenth 2004 Simvastatin treatment for inflammatory attacks of hyperimmunoglobulinaemia D and periodic fever syndrome Clin Pharmacol Ther 75 476 483 15116060 10.1016/j.clpt.2004.01.012 1:CAS:528:DC%2BD2cXjs1Cjtbk%3D (Pubitemid 38534568)
9. R Topaloglu NA Ayaz HR Waterham A Yüce F Gumruk Ö Sandal 2008 Hyperimmunoglobulinaemia D and periodic fever syndrome: treatment with etanercept and follow-up Clin Rheumatol 27 1317 1320 18506569 10.1007/s10067-008-0911-3
10. JP Drenth AG Vonk A Simon R Powell JW van der Meer 2001 Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial J Pharmacol Exp Ther 298 1221 1226 11504824 1:CAS:528:DC%2BD3MXmtFKmtbw%3D (Pubitemid 32761943)
11. K Takada I Aksentijevich V Mahadevan JA Dean RI Kelley DL Kastner 2003 Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinaemia D and periodic fever syndrome Arthritis Rheum 48 2645 2651 13130485 10.1002/art.11218 1:CAS:528:DC%2BD3sXot1Wjt7k%3D (Pubitemid 37129442)
12. E Demirkaya MK Caglar HR Waterham R Topaloglu S Ozen 2006 A patient with hyper IgD syndrome responding to anti-TNF treatment Clin Rheumatol 26 1757 1759 17171314 10.1007/s10067-006-0501-1
13. M Cailliez F Garaix C Rousset-Rouviere D Bruno I Kone-Paut J Sarles B Chabrol M Tsimaratos 2006 Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis J Inherit Metab Dis 29 763 17103011 10.1007/s10545-006-0408-7 1:STN:280:DC%2BD28nnvVansg%3D%3D
14. EJ Bodar JCH van der Hilst JPH Drenth JWM van der Meer A Simon 2005 Effect of etanercept and anakinra on inflammatory attacks in the hyper-IgD syndrome: introducing a vaccine provocation model Neth J Med 63 260 264 16093577 1:CAS:528:DC%2BD2MXhtVGnsbfL (Pubitemid 41179436)
15. D Rigante V Ansuini B Bertoni AL Pugliese L Avallone G Federico A Stabile 2006 Treatment with anakinra in hyperimmunoglobulinaemiaD/periodic fever syndrome Rheumatol Int 27 97 100 16871408 10.1007/s00296-006-0164-x (Pubitemid 44655757)
16. JP Drenth M van Deuren J van der Ven-Jongerkrijg CG Schalkwijk JW van der Meer 1995 Cytokine activation during attacks of hyperimmunoglobulinemia D and periodic fever syndrome Blood 85 3586 3593 7780142 1:CAS:528:DyaK2MXmtlOmtLc%3D
17. F Marchetti E Barbi A Tommasini C Oretti A Ventura 2004 Inefficacy of etanercept in a chid with hyper-IgD syndrome and periodic fever Clin Exp Rheumatol 22 791 792 15638064 1:STN:280:DC%2BD2M%2Fht1Ghug%3D%3D (Pubitemid 40045552)
18. M Nevyjel A Pontillo L Calligaris A Tommasini A D'Osualdo HR Waterham M Granzotto S Crovella E Barbi A Ventura 2007 Diagnostics and therapeutic insights in a severe case of mevalonate kinase deficiency Paediatrics 119 e523 e557 10.1542/peds.2006-2015 (Pubitemid 46397766)
19. T Lequerre O Vittecoq S Pouplin N Klemmer O Mejjad A Daragon AM Prieur X Le Loet 2007 Mevalonate kinase deficiency with structural damage responsive to anakinra Rheumatology 46 1860 1862 17965046 10.1093/rheumatology/kem258 1:CAS:528:DC%2BD2sXhtlKmtbfM (Pubitemid 350168307)